Lung cancer risk tied to ATM gene variants in Bangladesh population study
Lung cancer patients in Bangladesh exhibit a genetic association with specific single nucleotide polymorphisms in the ataxia-telangiectasia mutated gene. Researchers investigated the role of ATM regulatory variants to understand cancer susceptibility within the local population. The study examined 250 individuals consisting of lung cancer patients and healthy controls. Genotyping utilised polymerase chain reaction–restriction fragment length polymorphism analysis. Patients showed significantly lower body mass index, elevated erythrocyte sedimentation rate, and reduced red blood cell counts compared with controls.
Genetic associations and male susceptibility
Under the recessive model, the rs189037 AA genotype showed a nominal association with an increased risk of lung cancer. That odds ratio stood at 2.09 with a 95% confidence interval of 1.22 to 3.53 and a p-value of 0.01, uncorrected for multiple comparisons.
Researchers observed a stronger effect among males, where the odds ratio reached 2.19 with a p-value of 0.0097. Analyses stratified by age or smoking status revealed no significant associations.
In contrast, the rs227091 variant showed no significant association with lung cancer under any genetic model tested. Both single nucleotide polymorphisms conformed to Hardy–Weinberg equilibrium and exhibited linkage disequilibrium.
Haplotype analysis and regulatory functions
Haplotype analysis uncovered differing effects on disease risk across combinations. The AT haplotype associated with an increased lung cancer risk at an odds ratio of 1.445 and a p-value of 0.046.
Meanwhile, the GT haplotype conferred a protective effect with an odds ratio of 0.297 and a p-value below 0.0001. Bioinformatic approaches evaluated the potential regulatory functions of these variants.
| Genetic Model or Haplotype | Odds Ratio (OR) | 95% Confidence Interval | p-value |
|---|---|---|---|
| rs189037 AA Genotype (Recessive) | 2.09 | 1.22–3.53 | 0.01 |
| rs189037 AA Genotype (Males) | 2.19 | Not reported | 0.0097 |
| AT Haplotype Risk Association | 1.445 | Not reported | 0.046 |
| GT Haplotype Protective Effect | 0.297 | Not reported | < 0.0001 |
The rs227091 variant altered multiple microRNA binding sites in predictions. The rs189037 variant received a RegulomeDB score of 1a, which indicates strong regulatory potential.
Questions regarding Bangladeshi lung cancer genetics
What methods identified the gene variants?
Genotyping used polymerase chain reaction–restriction fragment length polymorphism analysis on 250 individuals comprising lung cancer patients and healthy controls, Nature reported.
What role does the ATM gene play?
The ataxia-telangiectasia mutated gene acts as a key regulator of the DNA damage response.
What are the next research steps?
Independent replication and validation in larger, multicenter cohorts are warranted to confirm these exploratory findings and elucidate the underlying molecular mechanisms.
Worth a look